NexoBrid
Pre-clinicalCompleted 0 views this week 0 watching💤 Quiet
Interest: 16/100
16
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedAbout NexoBrid
NexoBrid is a pre-clinical stage product being developed by MediWound for Thermal Burn. The current trial status is completed. This product is registered under clinical trial identifier NCT04040660. Target conditions include Thermal Burn.
What happened to similar drugs?
0 of 2 similar drugs in Thermal Burn were approved
Approved (0) Terminated (0) Active (2)
Hype Score Breakdown
Clinical
3
Activity
8
Company
5
Novelty
0
Community
0
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04040660 | Pre-clinical | Completed |
| NCT02278718 | Phase 3 | Completed |
Competing Products
4 competing products in Thermal Burn
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| R475 + Placebo | Sanofi | Phase 2 | 27 |
| cP12 | United Therapeutics | Phase 2 | 39 |
| NexoBrid + Gel Vehicle | MediWound | Phase 3 | 30 |
| NexoBrid | MediWound | Phase 3 | 30 |